Investing in The Cooper Companies, Inc. (COO)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)84.44-10
Intrinsic value (DCF)75.84-19
Graham-Dodd Method73.51-21
Graham Formula180.8293

Company description

COO, also known as Cooper Companies Inc., is a specialized global medical device and contact lens company. It was founded in 1958 and is headquartered in Pleasanton, California. The company operates through two main business segments: CooperVision and CooperSurgical. CooperVision is one of the world's leading manufacturers of contact lenses, catering to a wide range of vision correction needs. The segment offers a variety of soft, toric, multifocal, and specialty contact lenses under well-known brands such as Biofinity, Avaira, and Clariti. In addition, it also provides solutions and lens care products. CooperSurgical, on the other hand, focuses on women's health and fertility. It offers a comprehensive range of products and services, including medical devices, diagnostics, and genetics, to support healthcare professionals in improving patient outcomes. The company's strong presence in both the contact lens and women's health markets has helped it establish a global footprint, with operations in over 100 countries. It has a dedicated team of over 12,000 employees worldwide, committed to delivering innovative and high-quality products and services. COO's commitment to innovation and excellence has led to numerous achievements and recognition, including being named one of the World's Most Ethical Companies by Ethisphere for the past four consecutive years. In addition to its focus on delivering value to its customers, the company also prioritizes corporate social responsibility, implementing sustainable practices to reduce its environmental impact and supporting various charitable initiatives